Survey – Who takes supplements

May 8, 2018

A recent article entitled “Older Americans Are Hooked on Vitamins Despite Scarce Evidence They Work” was recently written by Liz Szabo for Kaiser Health News and later picked up by The New York Times. It is clear from the title this was not intended to be an unbiased piece of journalism. Ms. Szabo has not been on the list of vitamin critics but has been a well-rounded advocate/critic for health causes in general. She is a peer-recognized prize journalist as Senior Correspondent for Kaiser Health News. Ms. Szabo spent 12+ years as a USA Today Medical Reporter and has garnered over 64,000 Twitter followers. In short, her opinion is rightfully respected.

The article was first published on April 4, 2018, and by April 27, 2018 letters to the editor prompted the article “Readers Weigh In On Vitamin Use And The Big Pharma-Patient Advocacy Connection.”

The letters to the editor presented in the follow-up article largely criticized the pharmaceutical industry and the cost and conscience associated with same. The most entertaining of the responses which supported vitamins:

Older Americans are the evidence. They live longer, yes? What other proof would you like? – Pamela Shattuck, San Diego County, California

 Ms. Shattuck makes a good point. The statistics represented in the graphic do provide a degree of support by themselves. I personally would be more concerned if the majority of dietary supplements were taken by inexperienced, uneducated impoverished people. The fact that older, presumably wiser, more educated persons more capable of evaluating health benefits, with disposable income that support the dietary supplement industry is comforting.

The article expands upon the premise of a healthy population striving to be healthier:

“People who take vitamins tend to be healthier, wealthier and better educated than those who don’t, Kramer said. They are probably less likely to succumb to heart disease or cancer, whether they take supplements or not. That can skew research results, making vitamin pills seem more effective than they really are.”

There are definitely two ways to look at this same potential inconsistency.

The original article discusses studies that link vitamins to negative outcomes. The statement “Vitamin E nor folic acid supplements did anything to protect the heart” was supported by an inconclusive reference “Vitamin E had no benefit. Its effects on fatal cardiovascular events require further exploration.” More importantly, the preceding sentence to the one referenced was: “Dietary supplementation with n-3 PUFA (fish oil) led to a clinically important and statistically significant benefit.” Dietary Supplements cannot claim benefit for patients on a reactive basis for such traumatic events as a myocardial infarction (heart attack). In this referenced study one dietary supplement was deemed to be beneficial and the other was deemed to need further investigation. The latter dietary supplement was noted for its lack of benefit and the former dietary supplement providing demonstrated benefit was ignored. The takeaway presentation was vitamins cause harm. The article went on to say “Even worse, studies linked high-dose vitamin E to a higher risk of heart failureprostate cancer and death from any cause.” The references here point to use of synthetic vitamin E on chronically ill patients. The latter study is a meta-analysis of other studies. The original statement from the referenced Vitamin E meta-analysis is:


High-dosage (> or =400 IU/d) trials were often small and were performed in patients with chronic diseases. The generalizability of the findings to healthy adults is uncertain. Precise estimation of the threshold at which risk increases is difficult.


High-dosage (> or =400 IU/d) vitamin E supplements may increase all-cause mortality and should be avoided.

The words “may” and “healthy adults” were excluded from the article. Concern for the effects of natural origin ingredients versus petroleum based synthetic ingredients was also not mentioned.

The statement “…almost never find that vitamins prevent disease…” is confusing because none of the referenced studies were conducted on healthy populations. It is difficult to determine if people stayed healthy by taking vitamins when only unhealthy people were observed. The distortion in how the results were presented is misleading.
The National Institutes of Health has spent more than $2.4 billion since 1999 studying vitamins and minerals. A point that can be agreed upon is the opinion made by Dr. Barnett Kramer, director of cancer prevention at the National Cancer Institute “Yet for “all the research we’ve done, we don’t have much to show for it.” The argument made in the article is that the NIH has spent $2.4 billion since 1999. The argument not made though, is that  the NIH has spent over $100 billion between 2010 and 2016 to approve 210 new drugs. These points combine to indicate we are not conducting enough research on the benefits of dietary supplements. Science and society needs to replace industry as the driver for research dollars. Inequitable tax dollars are spent on studies to support pharmaceutical, not nutraceutical, research.


Currently, healthy population references to support dietary supplements are the statistics provided by surveys not science. Until dietary supplements can achieve significant dollars for the breadth and significance of science necessary to prove their benefits their primary support will have to continue to come from the economically successful, well educated, longevity minded people who take them.



Unlock the Power of Transparency: Schedule a Meeting Now

Ready to Illuminate Your Path?
Partner with Trust Transparency Today.

Get inTouch

Lori Diez

Lori Diez combines compassion and excellence to lead organizations to their next level. A small-town Texas childhood taught her the value of hard work and relationships, which she uses to foster teamwork that brings results that have transformed cultures and programs to their highest potential. Her successful career in pharmaceutical and nutraceutical sales leadership and event hosting has prepared her to deliver results as the COO of TrustTransparency, where she uses her industry knowledge to ensure that the company’s operations run smoothly as they support nutraceutical companies in their mission to help others. Lori’s passion for charity reflects her belief that individuals working together can change the world, no matter how small their contribution to the effort. This year, she looks forward to continuing over a decade of service at the Houston Livestock Show And Rodeo, where she will be the Chairman of the Livestock Committee.

Conference Handouts

Conference Handouts

CoQ10 Statin Associated Myaglia Meta Study Barry Tan 0618 Case Study

CoQ10 Statin Associated Myaglia Meta Study Barry Tan 0618 (1)

Statin Q10 Effect Case Study

Statin Q10 Effect Case Study

Schedule Consultation with Trust Transparency

Glynnda Steinford

Glynnda Steinford, Trust Transparency Consulting’s Director of Customer Relations, brings over four decades of healthcare experience to her vital role in client engagement and relationship building. Her diverse background spans from administering medical groups to impactful stints in pharmaceutical and nutraceutical sales, all underlined by her degree in Healthcare Administration.

At the heart of Glynnda’s work is her talent for nurturing long-term connections, a skill she leverages to enhance client experiences and partnerships within the consultancy. Beyond her professional commitments, she enjoys life’s simple pleasures, whether it’s her love for cats and cooking or her ventures into golf, always prioritizing cherished moments with family and friends. Her personal interests echo the dedication and warmth she extends in her professional network, making her an invaluable asset to the team.

Caiti Dowden

Caiti Dowden stands as a crucial pillar at Trust Transparency Consulting, bringing invaluable insight and expertise to her role as Senior Executive Assistant’ since her start in 2018. With an academic background from Sam Houston University and a career shift from education to the nutraceutical sphere in 2010, Caiti has cultivated a sharp acumen for dissecting industry trends and bolstering strategic decision-making.

Her transition from Data Analyst reflects her growth and deep understanding of the business landscape. Caiti’s commitment goes beyond professional excellence; she thrives on balance, drawing from her rich life outside of work to enhance her organizational contributions. Whether it’s family time, volunteering, or rooting for Houston’s sports teams, she believes in embracing experiences to fuel her professional creativity and insight.

In her current role, Caiti’s dedication to dynamic business analysis and operational support proves her to be an irreplaceable asset to our team, embodying the synergy of personal enrichment and professional success.

Pam Hilpert

Pam Hilpert, Chief of Staff at Trust Transparency Consulting, has been instrumental in the firm since its inception, leveraging her 17 years of accounting experience, including a significant tenure in the nutrition sector. Her collaboration with Scott Steinford spans various successful ventures, emphasizing her integral role in the company’s financial and strategic initiatives.

An alumnus of Sam Houston State University, Pam holds degrees in both Business Administration and Accounting, as well as an MBA, adding academic heft to her practical industry insights. Beyond her professional prowess, Pam is passionate about family, enjoys live music, delves into quilting, and volunteers at her church, reflecting her well-rounded life.

Her multifaceted expertise and longstanding dedication make Pam a cornerstone of Trust Transparency Consulting’s operational strength and team unity.

Scott Steinford

Scott Steinford, a trailblazer in strategic leadership, boasts a certified M&A background, having navigated companies from their genesis to industry prominence. His brainchild, Trust Transparency Consulting, born in 2007, stands as a testament to his dedication to ethical business practices and strategic foresight, offering industry stakeholders invaluable guidance.

Beyond founding and steering companies, Scott has enriched the business landscape with his insightful keynotes and prolific written contributions, emphasizing his commitment to elevating industry standards. His executive tenure shines in roles as CEO or President of for-profits like ZMC-USA and Doctor’s Best, extending to significant contributions in non-profit sectors.

Notably, Scott’s influence is a driving force in the CoQ10 market, where his leadership has significantly bolstered the ingredient’s global presence. His roles in various capacities, including as a New Hope Ambassador, keep the community informed, providing in-depth industry reports and insights.

An active advocate within professional associations and an Editorial Advisor for leading industry publications, Scott’s expertise is both recognized and sought after. With academic roots in Pre-Law and a Master’s in Law, his journey transcends textbooks, embodying real-world business acumen and transformative leadership.

Scott Steinford merges visionary entrepreneurship with principled leadership, creating a legacy of innovation, growth, and unwavering commitment to industry excellence.